We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Target Sequence Capture Panel Eases Detection of Viruses in Patient Samples

By LabMedica International staff writers
Posted on 14 Oct 2015
Print article
Image: A new test can detect virtually any virus that infects people and animals, including the Ebolavirus depicted in this enhanced electron micrograph (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).
Image: A new test can detect virtually any virus that infects people and animals, including the Ebolavirus depicted in this enhanced electron micrograph (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).
A recently developed targeted sequence capture panel, ViroCap, which was designed to enrich nucleic acid from DNA and RNA viruses that infect vertebrate hosts, allowed the rapid detection of unknown viruses in patient samples.

Metagenomic shotgun sequencing (MSS) is an important tool for characterizing viral populations. It is culture-independent, requires no a priori knowledge of the viruses in the sample, and may provide useful genomic information. However, MSS can lack sensitivity and may yield insufficient data for detailed analysis. To solve these problems investigators at Washington University School of Medicine (St. Louis, MO, USA) have created a targeted sequence capture panel, ViroCap, designed to enrich nucleic acid from DNA and RNA viruses from 34 families that infect vertebrate hosts.

During the development of ViroCap the investigators submitted consolidated target sequences to 454 Roche NimbleGen (Madison, WI, USA) for capture library design and 454 synthesis. This computational approach condensed nearly one billion base pairs (bps) of viral reference sequence into less than 200 million bps of unique, representative sequence suitable for targeted sequence capture. These sequences were used as probes to scoop up viruses in patient samples that were a genetic match. The matched viral material was analyzed using high-throughput genetic sequencing.

The investigators used ViroCap to analyze two sets of samples, one derived from samples submitted to a diagnostic virology laboratory and one derived from samples collected in a study of fever in children. They reported detecting 14 and 18 viruses in the two sets, respectively, comprising 19 genera from 10 families. Compared to standard genomics-based detection methods, 52% more viruses were found by the ViroCap method.

"With this test, you do not have to know what you are looking for," said senior author, Dr. Gregory Storch, professor of pediatrics at Washington University School of Medicine. "It casts a broad net and can efficiently detect viruses that are present at very low levels. We think the test will be especially useful in situations where a diagnosis remains elusive after standard testing or in situations in which the cause of a disease outbreak is unknown."

Details were published in the September 22, 2015, online edition of the journal Genome Research.

Related Links:

Washington University School of Medicine
454 Roche NimbleGen


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.